Patrick Hess

3.7k total citations
65 papers, 2.8k citations indexed

About

Patrick Hess is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Patrick Hess has authored 65 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 23 papers in Molecular Biology and 22 papers in Physiology. Recurrent topics in Patrick Hess's work include Nitric Oxide and Endothelin Effects (22 papers), Renin-Angiotensin System Studies (17 papers) and Receptor Mechanisms and Signaling (13 papers). Patrick Hess is often cited by papers focused on Nitric Oxide and Endothelin Effects (22 papers), Renin-Angiotensin System Studies (17 papers) and Receptor Mechanisms and Signaling (13 papers). Patrick Hess collaborates with scholars based in Switzerland, China and United States. Patrick Hess's co-authors include Martine Clozel, Changbin Qiu, Markus Rey, Walter Fischli, Jean‐Paul Clozel, Thomas Weller, Marc Iglarz, Oliver Nayler, Stephan Buchmann and Christoph A. Binkert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Patrick Hess

64 papers receiving 2.7k citations

Peers

Countries citing papers authored by Patrick Hess

Since Specialization

Citations

This map shows the geographic impact of Patrick Hess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Hess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Hess more than expected).

Fields of papers citing papers by Patrick Hess

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Hess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Hess. The network helps show where Patrick Hess may publish in the future.

Co-authorship network of co-authors of Patrick Hess

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Hess. A scholar is included among the top collaborators of Patrick Hess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Hess. Patrick Hess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacological Characterization of Aprocitentan, a Dual Endothelin Receptor Antagonist, Alone and in Combination with Blockers of the Renin Angiotensin System, in Two Models of Experimental Hypertension 2019 ·Journal of Pharmacology and Experimental Therapeutics ·F. Trensz, (unknown), (unknown), (unknown), (unknown), Markus Rey, Daniel S. Strasser, Stéphane Delahaye, Patrick Hess, Enrico Vezzali, (unknown), Joël Ménard, Martine Clozel, Marc Iglarz	42
2	Selexipag Active Metabolite ACT-333679 Displays Strong Anticontractile and Antiremodeling Effects but Low β-Arrestin Recruitment and Desensitization Potential 2017 ·Journal of Pharmacology and Experimental Therapeutics ·John Gatfield, Katalin Menyhart, (unknown), Carmela Gnerre, (unknown), Keith Morrison, Patrick Hess, Marc Iglarz, Martine Clozel, Oliver Nayler	27
3	Novel S1P1 receptor agonists – Part 5: From amino-to alkoxy-pyridines 2016 ·European Journal of Medicinal Chemistry ·Martin H. Bolli, Cyrille Lescop, Magdalena Birker, Ruben de Kanter, Patrick Hess, Christopher Kohl, Oliver Nayler, Markus Rey, Patrick Sieber, (unknown), Thomas Weller, Beat Steiner	12
4	Novel S1P 1 receptor agonists – Part 4: Alkylaminomethyl substituted aryl head groups 2016 ·European Journal of Medicinal Chemistry ·Cyrille Lescop, (unknown), (unknown), Magdalena Birker, Ruben de Kanter, Christopher Kohl, Patrick Hess, Oliver Nayler, Markus Rey, Patrick Sieber, Beat Steiner, Thomas Weller, Martin H. Bolli	11
5	REPEATED ORAL ADMINISTRATION OF THE SELECTIVE PROSTACYCLIN RECEPTOR AGONIST SELEXIPAG DOES NOT CAUSE TACHYPHYLAXIS IN SPONTANEOUSLY HYPERTENSIVE RATS 2015 ·Journal of the American College of Cardiology ·Keith Morrison, (unknown), John Gatfield, Carmela Gnerre, Patrick Hess, Martine Clozel	7
6	Discovery of novel bridged tetrahydronaphthalene derivatives as potent T/L-type calcium channel blockers 2015 ·Bioorganic & Medicinal Chemistry Letters ·Dorte Renneberg, (unknown), Markus Rey, Patrick Hess, Stéphane Delahaye, John Gatfield, Marc Iglarz, Kurt Hilpert	4
7	A Novel Genomic Signature with Translational Significance for Human Idiopathic Pulmonary Fibrosis 2014 ·American Journal of Respiratory Cell and Molecular Biology ·Yasmina Bauer, John Tedrow, Simon de Bernard, Magdalena Birker, Kevin F. Gibson, Brenda Juan Guardela, Patrick Hess, Axel Klenk, Kathleen O. Lindell, (unknown), Bérengère Renault, Markus Rey, Edgar Weber, Oliver Nayler, Naftali Kaminski	122
8	Comparison of pharmacological activity of macitentan and bosentan in preclinical models of systemic and pulmonary hypertension 2014 ·Life Sciences ·Marc Iglarz, (unknown), (unknown), (unknown), Markus Rey, Patrick Hess, Martine Clozel	37
9	The Selective Sphingosine 1-Phosphate Receptor 1 Agonist Ponesimod Protects against Lymphocyte-Mediated Tissue Inflammation 2011 ·Journal of Pharmacology and Experimental Therapeutics ·Luca Piali, Sylvie Froidevaux, Patrick Hess, Oliver Nayler, Martin H. Bolli, Eva Schlosser, Christopher Kohl, Beat Steiner, Martine Clozel	89
10	Surgical and pharmacological animal models used in drug metabolism and pharmacokinetics 2011 ·Xenobiotica ·(unknown), Patrick Hess, Alexander Treiber	3
11	Design and optimization of new piperidines as renin inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Olivier Corminboeuf, (unknown), Corinna Grisostomi, (unknown), Sylvia Richard‐Bildstein, Daniel Bur, Lars Prade, Patrick Hess, (unknown), Walter Fischli, Beat Steiner, Alexander Treiber	15
12	New classes of potent and bioavailable human renin inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Sylvia Richard‐Bildstein, Daniel Bur, Lars Prade, Olivier Corminboeuf, Christoph Boss, Corinna Grisostomi, Thierry Sifferlen, (unknown), Patrick Hess, Stéphane Delahaye, Alexander Treiber, Thomas Weller, Christoph A. Binkert, Beat Steiner, Walter Fischli	15
13	The Urotensin-II Receptor Antagonist Palosuran Improves Pancreatic and Renal Function in Diabetic Rats 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Martine Clozel, Patrick Hess, Changbin Qiu, (unknown), Markus Rey	71
14	Pharmacology of the Urotensin-II Receptor Antagonist Palosuran (ACT-058362; 1-[2-(4-Benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea Sulfate Salt): First Demonstration of a Pathophysiological Role of the Urotensin System 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Martine Clozel, Christoph A. Binkert, Magdalena Birker, (unknown), Shuangshuang Ding, Walter Fischli, Patrick Hess, (unknown), Keith Morrison, (unknown), (unknown), Oliver Nayler, Changbin Qiu, Markus Rey, Michael W. Scherz, (unknown), Thomas Weller, (unknown), (unknown)	108
15	The use of sulfonylamido pyrimidines incorporating an unsaturated side chain as endothelin receptor antagonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·Martin H. Bolli, Christoph Boss, Martine Clozel, Walter Fischli, Patrick Hess, Thomas Weller	9
16	Chronic Endothelin Receptor Blockade Prevents Both Early Hyperfiltration and Late Overt Diabetic Nephropathy in the Rat 2003 ·Journal of Cardiovascular Pharmacology ·Shuangshuang Ding, Changbin Qiu, Patrick Hess, (unknown), Nan Zheng, Martine Clozel	51
17	Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarction 2002 ·Journal of the American College of Cardiology ·Martine Clozel, Changbin Qiu, Chang-Shen Qiu, Patrick Hess, Jean‐Paul Clozel	39
18	Age-dependent hypertension in Mpv17-deficient mice, a transgenic model of glomerulosclerosis and inner ear disease 1999 ·Experimental Gerontology ·(unknown), Patrick Hess, Walter Fischli, Bernd‐Michael Löffler, Ralf M. Zwacka, (unknown), Hans Weiher	9
19	Major role of the renin angiotensin system in the neointima formation after vascular injury in guinea pigs 1994 ·Life Sciences ·Jean‐Paul Clozel, Patrick Hess, (unknown), Volker Breu, Walter Fischli, (unknown)	9
20	Hemodynamic Profile of Ro 40–5967 in Conscious Rats 1991 ·Journal of Cardiovascular Pharmacology ·Murielle M. Véniant, Jean‐Paul Clozel, Patrick Hess, (unknown)	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact